Alkermes Raises FY2026 GAAP EPS Guidance from $(0.80)-$(0.68) to $(0.52)-$(0.41) vs $(0.54) Est; Affirms FY2026 Sales Guidance of $1.730B-$1.840B vs $1.798B Est
Financial Expectations for 2026In connection with the purchase price accounting related to the acquisition of Avadel, the company is updating certain non-cash elements of its 2026 full year financial expectations,
